RT Journal Article
T1 Impact of Age at Diagnosis on Clinicopathological Features, Prognosis, and Management of Gastric Cancer: A Retrospective Single-Center Experience from Spain
A1 Estrada Muñoz, Lourdes
A1 Molina Roldán, Elena
A1 García Gómez de las Heras, Soledad
A1 Díaz Del Arco, Cristina
A1 Ortega Medina, Luis
A1 Fernández Aceñero, María Jesús
AB The incidence of renal mass detection has increased during recent decades, with an increased diagnosis of small renal masses, and a final benign diagnosis in some cases. To avoid unnecessary surgeries, there is an increasing interest in using radiomics tools to predict histological results, using radiological features. We performed a narrative review to evaluate the use of radiomics in renal mass characterization. Conventional images, such as computed tomography (CT) and magnetic resonance (MR), are the most common diagnostic tools in renal mass characterization. Distinguishing between benign and malignant tumors in small renal masses can be challenging using conventional methods. To improve subjective evaluation, the interest in using radiomics to obtain quantitative parameters from medical images has increased. Several studies have assessed this novel tool for renal mass characterization, comparing its ability to distinguish benign to malign tumors, the results in differentiating renal cell carcinoma subtypes, or the correlation with prognostic features, with other methods. In several studies, radiomic tools have shown a good accuracy in characterizing renal mass lesions. However, due to the heterogeneity in the radiomic model building, prospective and external validated studies are needed.
PB MPDI
YR 2023
FD 2023-08-24
LK https://hdl.handle.net/20.500.14352/103456
UL https://hdl.handle.net/20.500.14352/103456
LA eng
NO Díaz del Arco, C.; Ortega Medina, L.; Estrada Muñoz, L.; Molina Roldán, E.; García Gómez de las Heras, S.; Fernández Aceñero, M.J. Impact of Age at Diagnosis on Clinicopathological Features, Prognosis, and Management of Gastric Cancer: A Retrospective Single-Center Experience from Spain. Cancers 2023, 15, 4241. https://doi.org/10.3390/cancers15174241
DS Docta Complutense
RD 20 jul 2024